“…The high penetrance and resemblance of the embryonic CVP malformation to multicavernous CCM suggest that it will be a useful phenotype for pharmacologic or morpholino-based analyses. That said, the CVP does lacks CNS accessory cells, such as astrocytes, (Lopez-Ramirez et al, 2021) that that promote CCM development. Indeed, we recently reported that propranolol blocks the embryonic CVP malformation by β1 adrenergic receptor antagonism (Li et al, 2021), a result that comports with the beneficial effects of propranolol in murine CCM models (Li et al, 2021;Oldenburg et al, 2021) and in anecdotal reports in humans (Lanfranconi et al, 2020;Reinhard et al, 2016).…”